Elai Davicioni (@davicioni) 's Twitter Profile
Elai Davicioni

@davicioni

Medical Director, Urology

ID: 2568042619

linkhttp://www.veracyte.com calendar_today15-06-2014 00:33:48

396 Tweet

574 Followers

601 Following

UroToday.com (@urotoday) 's Twitter Profile Photo

Risk assessment in localized #ProstateCancer - Insights from real-world data and SEER registry. Jim Hu Weill Cornell Medicine joins Ashley Ross MD PhD NM Urology to discuss the use of genomic classifiers in the mgmt of localized PCa on UroToday > bit.ly/3VSVvJc Decipher by Veracyte

Risk assessment in localized #ProstateCancer - Insights from real-world data and SEER registry. <a href="/jimhumd/">Jim Hu</a> <a href="/WeillCornell/">Weill Cornell Medicine</a> joins <a href="/ashleyrossmdphd/">Ashley Ross MD PhD</a> <a href="/NM_Urology/">NM Urology</a> to discuss the use of genomic classifiers in the mgmt of localized PCa on UroToday &gt; bit.ly/3VSVvJc <a href="/Decipher_VCYT/">Decipher by Veracyte</a>
Zach Klaassen (@zklaassen_md) 's Twitter Profile Photo

Cross-Comparison IPD Analysis of Three Gene Expression Signatures in Localized #prostatecancer in >50,000 Men #ASTRO23 Angela Jia UroToday.com 📌 15,379 NCCN low-risk, 14,773 fav int-risk, 15,544 unfav int-risk, and 5,185 high/very high-risk 📌 Oncotype model had poor

Cross-Comparison IPD Analysis of Three Gene Expression Signatures in Localized #prostatecancer in &gt;50,000 Men #ASTRO23 <a href="/angela_jia_/">Angela Jia</a> <a href="/urotoday/">UroToday.com</a> 

📌 15,379 NCCN low-risk, 14,773 fav int-risk, 15,544 unfav int-risk, and 5,185 high/very high-risk
📌 Oncotype model had poor
Decipher by Veracyte (@decipher_vcyt) 's Twitter Profile Photo

We will be attending the Society of Urologic Oncology meeting it will be taking place on November 28th - December 1st 2023 in Washington, DC! Visit our booth & learn how Veracyte, Inc.'s Decipher Prostate GC can help men living with #ProstateCancer

We will be attending the Society of Urologic Oncology meeting it will be taking place on November 28th - December 1st 2023 in Washington, DC! 

Visit our booth &amp; learn how <a href="/Veracyte/">Veracyte, Inc.</a>'s Decipher Prostate GC can help men living with #ProstateCancer
Piet Ost (@piet_ost) 's Twitter Profile Photo

Open for inclusion: Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers (THUNDER): A Two-part Phase 2/ 3 Trial.

Open for inclusion: Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers (THUNDER):  A Two-part Phase 2/ 3 Trial.
Todd 〽️ Morgan, MD (@wandering_gu) 's Twitter Profile Photo

Awesome study led by Udit Singhal, MD and Robert Dess combining STAR-CAP prognostic score with genomic risk using Decipher by Veracyte GRID as well as MUSIC Urology data. Gives a cool picture of how clinical and genomic risk differ and can be additive. #AUA24

Awesome study led by <a href="/theusinghal/">Udit Singhal, MD</a> and <a href="/rtdess/">Robert Dess</a> combining STAR-CAP prognostic score with genomic risk using <a href="/Decipher_VCYT/">Decipher by Veracyte</a> GRID as well as <a href="/MUSICUrology/">MUSIC Urology</a> data. Gives a cool picture of how clinical and genomic risk differ and can be additive. #AUA24
Lars Dyrskjøt (@ldyrskjot) 's Twitter Profile Photo

Our latest paper on ctDNA detection using WGS is now published in European Urology. This WGS-based approach simplifies clinical workflows by eliminating the need for personalized assays. Read the paper here : doi.org/10.1016/j.euru…

Our latest paper on ctDNA detection using WGS is now published in <a href="/EuropeanUrology/">European Urology</a>.  This WGS-based approach simplifies clinical workflows by eliminating the need for personalized assays. Read the paper here : doi.org/10.1016/j.euru…
European Urology (@euplatinum) 's Twitter Profile Photo

Articles in Press: Whole-genome Mutational Analysis for Tumor-informed Detection of Circulating Tumor DNA in Patients with Urothelial Carcinoma by Iver Nordentoft and Sia Viborg Lindskrog et al Read the full article here: europeanurology.com/article/S0302-… #UroSoMe #Medtwitter #BladderCa

Articles in Press: Whole-genome Mutational Analysis for Tumor-informed Detection of Circulating Tumor DNA in Patients with Urothelial Carcinoma by <a href="/IverNordentoft/">Iver Nordentoft</a> and <a href="/SiaLindskrog/">Sia Viborg Lindskrog</a> et al 

Read the full article here: europeanurology.com/article/S0302-… 

#UroSoMe #Medtwitter #BladderCa
Michael Leapman (@mleapman) 's Twitter Profile Photo

Excited to share our manuscript addressing a novel linkage between the Decipher genomic classifier and real-world clinical data with >92,000 patients securely linked jamanetwork.com/journals/jaman… Chris Filson Tyler Seibert MD PhD Decipher by Veracyte Elai Davicioni Matt Cooperberg

Veracyte, Inc. (@veracyte) 's Twitter Profile Photo

A new study in JCO Precision Oncology shows that Decipher Prostate results align with cancer spread found on PSMA PET in #ProstateCancer patients pre- and post-treatment. Results suggest Decipher testing could help determine which patients need a PSMA PET scan.

Emmanuel Antonarakis (@eantonarakis) 's Twitter Profile Photo

Huge congrats to Cathy Handy Marshall, MD MPH and Benjamin Teply for this paradigm-breaking study. In BCR prostate cancer, Olaparib shows profound activity (w/out ADT!) in HRRm+ pts, esp. in BRCA2+ pts (100% response rate). The PCCTC Johns Hopkins Kimmel Cancer Center @umncancer jamanetwork.com/journals/jamao…

Huge congrats to <a href="/CathyHandy/">Cathy Handy Marshall, MD MPH</a> and <a href="/BenTeply/">Benjamin Teply</a> for this paradigm-breaking study.  In BCR prostate cancer, Olaparib shows profound activity (w/out ADT!) in HRRm+ pts, esp. in BRCA2+ pts (100% response rate).  <a href="/ThePCCTC/">The PCCTC</a>  <a href="/hopkinskimmel/">Johns Hopkins Kimmel Cancer Center</a> @umncancer jamanetwork.com/journals/jamao…